Össur hf: Share Buyback Program Completed
Announcement no. 56/2022
7 October 2022
On 14 February 2022, Össur hf. initiated a share buyback program (“Program”), see Company Announcement no. 05/2022.
The purpose of the Program was to reduce the Company’s share capital and adjust the capital structure by distributing capital to shareholders in line with the Company’s Capital Structure and Capital Allocation Policy. The Program would end no later than 23 December 2022. The Company could purchase up to 2,000,000 shares under the Program, corresponding to 0.47% of the current share capital. The total consideration for shares purchased under the Program should not exceed USD 10 million.
Following are the last transactions made under the Program in the period 3 October 2022 – 6 October 2022.
| Transactions | ||||
| Date | No. of shares | Avg. purchase price in DKK | Transaction value in DKK | |
| 3 October 2022 | 3,061 | 30.22 | 92,507 | |
| 4 October 2022 | 23,189 | 31.34 | 726,657 | |
| 5 October 2022 | 27,718 | 31.96 | 885,998 | |
| 6 October 2022 | 14,269 | 32.35 | 461,602 | |
| Total | 68,237 | 31.75 | 2,166,765 | |
Össur acquired 2,000,000 shares under the Program at the average price of DKK 33.47 and thus the program has been completed. Following the above transactions, Össur currently holds 2,613,113 shares, corresponding to 0.62% of the Company’s total share capital.
The Program on Nasdaq Copenhagen was carried out in accordance with Regulation No. 596/2014 of the European Parliament and of the Council on market abuse ("MAR"), and the Commission’s delegated regulation 2016/1052.
Further information
Edda Lára Lúðvígsdóttir, Investor Relations Director, eludvigsdottir@ossur.com, +354 844 4759
Össur press releases by e-mail
If you wish to receive Össur press releases by e-mail, please register at http://www.ossur.com/investors
About Össur
Össur (Nasdaq Copenhagen: OSSR) is a global leader in non-invasive orthopaedics that helps people live a Life Without Limitations. A recognized “Technology Pioneer” with a rich 50-year history, Össur focuses on improving people’s mobility through the delivery of innovative technologies in Prosthetics and Bracing & Supports. Significant investment in research and development have led to over 2,000 patents, award-winning designs, successful clinical outcomes, and consistently strong market positions. Össur is signatory to the UN Global Compact, UN Women’s Empowerment Principles, contributes to the UN Sustainable Development Goals and became Carbon Neutral in 2021. Össur operates globally and employs around 4,000 employees. www.ossur.com